NANBIOSIS’s Protein Production Platform showcased innovations in protein engineering at PEGS Europe 2024, featuring talks, posters, and session moderation.
Barcelona, november 2024. Last month, the NBT group and Unit 1 of NANBIOSIS (Protein Production Platform, PPP), from CIBER-BBN and IBB-UAB, was invited once again to participate in the prestigious PEGS Europe conference.
PEGS Europe, a prestigous conference
This year, the 16th PEGS Europe conference was held in Barcelona from November 5th to 7th. PEGS, or the Protein & Antibody Engineering Summit, is organized by the Cambridge Healthtech Institute (CHI) and is renowned for its focus on protein engineering and its applications in drug discovery, development, and delivery.
The NBT group and PPP from NANBIOSIS have been invited again to participate in the congress through two invited oral presentations and two posters, one of them also invited. Therefore, the PPP technical coordinator has been also invited to moderate the “protein process development” session.
The participation of our Protein Production Platform
Dr. Eric Voltà group presented the invited talk ‘Expanding the Boundaries of E.coli Disulfide-Rich Protein Nanoparticles That Selectively Destroy Cancer-Associated Fibroblasts’ within the track ‘Cell Line and Systems Engineering’.
Dr. Jose Luís Corchero Nieto presented the invited talk ‘Production of Vault-Like Nanoparticles in a Prokaryotic Expression System’ inside the ‘Protein Process Development’ track.
Roger Fernandez Palomeras exposed the poster ‘Engineering Recombinant Human Vaults to Target Cancer Stem Cells’.
Dr. Merce Márquez Martínez, technical coordinator of Unit 1 (PPP), was invited to moderate the ‘Protein Process Development’ track, present the poster ‘Optimization of Protein Solubility and Recovery of Precipitated Proteins’. She also has contributed as a co-author of the invited talk ‘Ferritin Vaccine Platform for Multiple Displays of IHNV Glycoprotein’ in the ‘Optimising Expression Platforms’ track by Sohrab Ahmadivand.
This invitation solidifies the prestige of our Protein Production Platform and the researchers involved in it. With its focus on transversal application of protein engineering, this event contributes significantly to find new solutions to overcome current healthcare challenges and foster collaboration with our researchers.
What is NANBIOSIS?
The goal of NANBIOSIS is to provide comprehensive and integrated advanced solutions for companies and research institutions in biomedical applications. All of this is done through a single-entry point, involving the design and production of biomaterials, nanomaterials, and their nanoconjugates. This includes their characterization from physical-chemical, functional, toxicological, and biological perspectives (preclinical validation).
In order to access our Cutting-Edge Biomedical Solutions with priority access, enter our Competitive Call here.
NANBIOSIS has worked with pharmaceutical companies of all sizes in the areas of drug delivery, biomaterials and regenerative medicine. Here are a few of them:
